#China #Shanghai #Inc. #111 #YI #Water Tower Research

111, Inc. to Participate in Fireside Chat with Water Tower Research

111, Inc. (NASDAQ: YI), a prominent player in the tech-enabled healthcare platform space, is set to feature in a fireside chat scheduled for March 26, 2025. This conversational event will involve Robert Sassoon, a senior research analyst from Water Tower Research, and the discussion will primarily focus on the company's anticipated achievements and strategic goals for 2025.

Key Highlights of the Event

During the session, Junling Liu, the Co-Founder and CEO of 111, Inc., will provide insights into the company's fourth quarter earnings for the fiscal year 2024, which are slated to be announced on March 20, 2025. Attendees can look forward to learning about the company's focus on reshaping the healthcare value chain in China through its innovative digital solutions aimed to empower both upstream and downstream players in the industry.

Furthermore, Liu will elaborate on the operational priorities set for 2025 and share an updated overview of the macroeconomic environment impacting the healthcare sector. This interaction aims to give stakeholders a comprehensive view of the company's performance and strategic direction.

Registration and Replay Access

Individuals wishing to attend the fireside chat can register through the provided link. This will be a one-way listening event wherein participants can absorb valuable information shared by the company’s executives. Following the event, a replay of the discussion will be made available on the investor relations section of 111's website, allowing those who couldn’t attend live to access the insights shared.

For those interested in exploring how 111, Inc. is enhancing access to healthcare in China, the event will serve as a pivotal opportunity for investors and analysts to gather data on the company’s market position and vision.

About 111, Inc.

Founded with the mission to revolutionize the healthcare industry, 111, Inc. operates as a tech-enabled platform that consolidates various healthcare services into an efficient access point for consumers. The company operates through several key digital channels.

1. 1 Pharmacy: An online retail pharmacy that allows consumers to purchase pharmaceutical products directly.
2. 1 Clinic: An internet hospital platform delivering convenient online medical consultations, electronic prescriptions, and management services.
3. 1 Medicine: A resourceful tool for pharmacies to source diverse pharmaceutical offerings, effectively creating a unified shopping experience for healthcare providers.

In addition to these services, 111, Inc. supports pharmacies in China by providing them with cloud-based solutions that assist in optimizing service delivery. The company also offers an omni-channel drug commercialization platform, which supplies strategic partners with various supportive services such as digital marketing, data analytics, and patient education.

With its commitment to improving healthcare access and outcomes through technology, 111, Inc. stands as a leader in the evolving landscape of health and wellness in China. To know more about 111, Inc. and their ongoing innovations, stakeholders can visit their official investor relations page at http://ir.111.com.cn/.

Conclusion

The forthcoming fireside chat represents a significant avenue for learning about the strategic initiatives of 111, Inc. in a rapidly changing healthcare environment. Participants are encouraged to leverage this opportunity to gain insight into the company's future trajectory as it continues to pioneer advancements within the healthcare sector.